GL1X · GenesisL1 explorer

MolNFT v1 · #107576 · protein

Crystal structure of the human carboxypeptidase A1 in complex with the phosphinic inhibitor acetyl-tyr-ala-Y(PO2CH2)-homophe-oh

4UEF: “Crystal structure of the human carboxypeptidase A1 in complex with the phosphinic inhibitor…”. X-ray diffraction, 2 ligands (TJE, ZN), 1 pocket (best druggability 0.82). MolNFT v1 #107576 on GenesisL1: 3D structure, binding sites…

PDB
4UEF
Type
protein
Length
613 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Carboxypeptidase A1
EC
3.4.17.1
UniProt
P15085
Ligands
TJE, ZN
Pockets
1 · best druggability 0.82

Structure

x-ray diffraction · 2 distinct chains · 38% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACarboxypeptidase A1 (EC 3.4.17.1)protein30638% helix, 18% strandP15085
BCarboxypeptidase A1 (EC 3.4.17.1)protein30739% helix, 18% strandP15085

Ligands and binding sites

  • TJE · (2S)-2-{[(S)-{(1R)-1-[(N-acetyl-L-tyrosyl) amino]ethyl}(hydroxy)phosphoryl]methyl}-4-phenylbutanoic acid · ligand · 2 copies · chains A, B
  • ZN · Zinc ion · metal · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110140.820.83106TJE, ZN

Interfaces

1 interface between chains.

  • A–B · 665 Ų buried · 5 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 disulfide (disulfide).

Compared structures

  • P15085 · AlphaFold monomer V2.0 prediction for carboxypeptidase A1 (P15085) · a predicted model of the same protein · chain B against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.